 Indian Express |
CORRECT: Piramal Not To Make Generic Drugs For Sale In India For 8 Years
Wall Street Journal ("Piramals Not To Make Generic Drugs For Sale In India For 8 Years," at 0724 GMT, misstated the company name in the headline. Abbott to Buy Piramal Generics Unit in India for $3.72 Billion Abbott's Healthy Piramal Deal |
Related posts:
- Pfizer Sues Teva Over Generic Viagra – Wall Street Journal
- Sprint’s First 4G Phone to Go on Sale June 4 – Wall Street Journal
- When Choosing to Buy Generic Ciali
- Using Biomarkers to Tailor Cancer Treatment – Wall Street Journal
- Ex-NBC Exec Ben Silverman: Opportunities Exist For TV Start-Ups – Wall Street Journal